Navigation
The Launching Meeting on Talent Cultivation on Safe Medicine of Beijing in 2018 Held
From:Beijing Municipal Commission of Health and Family Planning
Date:04/28/2018

 

In order to build a close-connected medical consortium and promote safe drug use in communities, on April 3, 2018, with the unified deployment of the Drug and Equipment Department of Beijing Municipal Commission of Health and Family Planning, the leading unit of the prescription review work of Beijing communities, Beijing Luohe Hospital of Capital Medical University, together with the National Center for Cardiology Diseases, Medical Consortium on Hypertension of Fuwai Hospital and some leading units of regional medical consortium jointly held the launching meeting of “Construction of Beijing Medical Consortium for Chronic Diseases and Promotion of Communities Talents Cultivation on Safety Medicine of 2018”. Nearly 400 people from the physicians from community medical units, representatives of pharmacists, heads of management departments on drug safety in various communities, and some pharmacy specialists and clinical experts from general hospitals attended the meeting.

Director of the Drug and Equipment Department of the Beijing Municipal Commission of Health and Family Planning Yue Xiaolin introduced the changes in the type and amount of drugs used by community medical institutions in the year before and after the comprehensive reform of Beijing's separation of clinic from pharmacy in 2017. The director of the prescription review working group Chen Shicai introduced the work content of the community prescription review in Beijing in recent years to the participating experts and community representatives. Professor Cai Jun, Director of the Center for Hypertension of Fuwai Hospital of the Chinese Academy of Medical Sciences, Chairman of the Hypertensive Disease Expert Committee of the National Center for Cardiovascular Diseases, and Chairman of the Medical Consortium of the National Center for Cardiovascular Disease on Hypertensive Disease, made a report on “Construction of Beijing Medical Consortium for Chronic Diseases and Promotion Plan of Communities Talents Cultivation on Safety Medicine”. Director Ji Liwei from the Department of Pharmacy of the Beijing Hospital, representing the Beijing Community Prescription Review Working Group, detailed the specific work plans and measures for the development of the Beijing Medical Consortium and the promotion of safe drug use in communities of 2018. Deputy Director and Chief Physician of General Hospital of Beijing Tiantan Hospital, Ma Li, Ma Wenjun, Chief Physician of Hypertension Center of Fuwai Hospital, Former Director Sun Chunhua from the Department of Pharmacy of Beijing Hospital attended the meeting and delivered speeches.

The conference is a tailor-made launching meeting by "national experts" for communities on safe drug use. In the future, we will unite medical consortium units of all districts to periodically and systematically conduct the discovery and cultivation of community safety drug talents through the training of safe medication knowledge, centralized prescription reviews, training and tutors guiding for prescribing skills, etc., to reduce unreasonable medicine use from the source.